GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
New York Community Bancorp, Inc. (NYCB) [hlAlert]

Rating:
Buy NYCB
up 7.73 %

New York Community Bancorp, Inc. (NYCB) upgraded to Buy with price target $19 by Standpoint Research

Posted on: Friday,  Oct 30, 2015  2:25 PM ET by Standpoint Research

Standpoint Research rated Buy New York Community Bancorp, Inc. (NYSE: NYCB) on 10/30/2015, when the stock price was $16.30.
Since then, New York Community Bancorp, Inc. has gained 7.73% as of 11/02/2015's recent price of $17.56.
If you would have followed this Standpoint Research's recommendation on NYCB, you would have gained 7.73% of your investment in 3 days.

New York Community Bancorp, Inc. is the holding company for New York Community Bank (the Community Bank) and New York Commercial Bank (the Commercial Bank). The Company has 212 banking offices serving customers in all five boroughs of New York City, Long Island, and Westchester County in New York, and Essex, Hudson, Mercer, Middlesex, Monmouth, Ocean, and Union counties in New Jersey. The Community Bank has 177 locations that operate through five local divisions: Queens County Savings Bank, Roslyn Savings Bank, Richmond County Savings Bank, Roosevelt Savings Bank and Garden State Community Bank. The Commercial Bank has 35 branches serving Manhattan, Queens, Brooklyn, Westchester County, and Long Island, including 18 branches of Atlantic Bank.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/30/2015 2:25 PM Buy
None
16.30 19.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  5.91 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/13/2015 4:25 PM Hold
None
17.37
9/16/2014 10:25 AM Buy
None
16.40 20.00
10/14/2013 11:25 AM Hold
None
15.57
3/7/2013 3:25 PM Buy
None
13.59
3/23/2012 11:25 AM Hold
None
13.55
12/15/2011 10:25 AM Buy
None
12.04 16.00
2/12/2010 11:25 AM Hold
None
15.56
9/16/2009 1:25 PM Buy
None
11.72

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy